CLINICAL OUTCOMES AND BIOMARKER NORMALISATION RESPONSE AT WEEK 16 IN PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO PRIOR BIOLOGICS IN THE POWER TRIAL
Stefan Schreiber 1
Scott Lee 2
C. Janneke van der Woude 3
Ignacio Marín-Jiménez 4
Doug Wolf 5
Elisabeth Schnoy 6
Bruce Salzberg 7
Christopher Busse 8
Maciek Nazar 9
Wayne Langholff 10
Chris Gasink 10
Thomas Baker 10
Bridget Godwin 10
Brian G. Feagan 11
1 Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany
2 University of Washington, Seattle, United States
3 Erasmus University Medical Center, Rotterdam, Netherlands
4 Hospital Universitario Gregorio Marañón, IiSGM, Madrid, Spain
5 Atlanta Gastroenterology Associates, Atlanta, United States
6 University Hospital of Augsburg, Augsburg, Germany
7 IBD Center of Atlanta, Atlanta, United States
8 Janssen Scientific Affairs, LLC, Horsham, United States
9 Janssen-Cilag Polska Sp. z o.o., Warsaw, Poland
10 Janssen Research & Development, LLC, Spring House, United States
11 University of Western Ontario, London, Canada
Topic
Endoscopy, Gut Microbiota, IBD
Conference
UEG Week Copenhagen 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]